The startup has developed a vision tracking system that employs an Automatic Visual Impairment Detection System utilizing a gaze-tracking algorithm for non-invasive monitoring of central vision deterioration. This technology provides users with precise assessments of visual performance, helping to prevent further loss of central vision and enhance overall quality of life.
Funding
$340K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Patients with age-related macular degeneration (AMD) require frequent monitoring by retinal specialists to track disease progression. Current monitoring methods often involve regular clinic visits, which can be challenging due to scheduling difficulties and patient compliance issues, potentially leading to delayed intervention and irreversible vision loss.
Solution
Occutrack offers a mobile gaze-tracking system that enables remote monitoring of central vision performance for individuals with AMD. The system utilizes a patented Automated Vision Assessment and Impairment Detection through Gaze Analysis (AVIGA) system. By tracking optokinetic eye movements in response to displayed patterns, the system assesses visual acuity, allowing patients to monitor their condition from home. This approach aims to reduce the need for frequent clinic visits and facilitate timely therapeutic intervention.
Target Audience
The primary target audience includes individuals with age-related macular degeneration (AMD) and retinal specialists involved in their care.
Features
- Mobile gaze-tracking technology for remote monitoring of visual performance.
- Patented AVIGA system employing sophisticated eye-tracking algorithms.
- Assessment of visual acuity based on tracking optokinetic eye movements.
- Home-based monitoring to reduce the frequency of clinic visits.
- Early detection of visual deterioration to enable timely intervention.